AR204075A1 - Procedimiento para la produccion de una vacuna de virus atenuados que estimula los mecanismos naturales de defensa de un organismo hospedador sin ejercer simultaneamente una accion de antigeno - Google Patents

Procedimiento para la produccion de una vacuna de virus atenuados que estimula los mecanismos naturales de defensa de un organismo hospedador sin ejercer simultaneamente una accion de antigeno

Info

Publication number
AR204075A1
AR204075A1 AR245553A AR24555372A AR204075A1 AR 204075 A1 AR204075 A1 AR 204075A1 AR 245553 A AR245553 A AR 245553A AR 24555372 A AR24555372 A AR 24555372A AR 204075 A1 AR204075 A1 AR 204075A1
Authority
AR
Argentina
Prior art keywords
stimulates
procedure
production
host organism
virus vaccine
Prior art date
Application number
AR245553A
Other languages
English (en)
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AR204075A1 publication Critical patent/AR204075A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16732Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761Methods of inactivation or attenuation
    • C12N2710/16764Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AR245553A 1971-12-10 1972-01-01 Procedimiento para la produccion de una vacuna de virus atenuados que estimula los mecanismos naturales de defensa de un organismo hospedador sin ejercer simultaneamente una accion de antigeno AR204075A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2161344A DE2161344C3 (de) 1971-12-10 1971-12-10 Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend

Publications (1)

Publication Number Publication Date
AR204075A1 true AR204075A1 (es) 1975-11-20

Family

ID=5827622

Family Applications (1)

Application Number Title Priority Date Filing Date
AR245553A AR204075A1 (es) 1971-12-10 1972-01-01 Procedimiento para la produccion de una vacuna de virus atenuados que estimula los mecanismos naturales de defensa de un organismo hospedador sin ejercer simultaneamente una accion de antigeno

Country Status (21)

Country Link
JP (2) JPS5924137B2 (OSRAM)
AR (1) AR204075A1 (OSRAM)
AT (1) AT326817B (OSRAM)
AU (1) AU473209B2 (OSRAM)
BE (1) BE792484A (OSRAM)
BG (1) BG21417A3 (OSRAM)
CA (1) CA988848A (OSRAM)
CH (1) CH577558A5 (OSRAM)
CS (1) CS189587B2 (OSRAM)
DD (1) DD108115A5 (OSRAM)
DE (1) DE2161344C3 (OSRAM)
DK (1) DK143201C (OSRAM)
ES (1) ES409464A1 (OSRAM)
FR (1) FR2162637B1 (OSRAM)
GB (1) GB1356076A (OSRAM)
HU (1) HU167086B (OSRAM)
IE (1) IE36995B1 (OSRAM)
NL (1) NL178014C (OSRAM)
PH (1) PH12597A (OSRAM)
SE (1) SE8400283L (OSRAM)
ZA (1) ZA728709B (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063657A1 (en) * 1981-04-29 1982-11-03 Merck & Co. Inc. Topical application of interferon inducers

Also Published As

Publication number Publication date
CH577558A5 (OSRAM) 1976-07-15
DD108115A5 (OSRAM) 1974-09-05
IE36995B1 (en) 1977-04-13
AU4992072A (en) 1974-06-13
DE2161344B2 (de) 1980-05-08
JPS4862919A (OSRAM) 1973-09-01
JPS5924137B2 (ja) 1984-06-07
FR2162637B1 (OSRAM) 1976-07-02
IE36995L (en) 1973-06-10
ZA728709B (en) 1973-08-29
CA988848A (en) 1976-05-11
JPS6011013B2 (ja) 1985-03-22
BE792484A (fr) 1973-06-08
AT326817B (de) 1975-12-29
NL178014B (nl) 1985-08-01
SE8400283D0 (sv) 1984-01-20
BG21417A3 (bg) 1976-05-20
PH12597A (en) 1979-06-27
DK143201B (da) 1981-07-20
DK143201C (da) 1981-12-14
JPS4862912A (OSRAM) 1973-09-01
NL178014C (nl) 1986-01-02
NL7216628A (OSRAM) 1973-06-13
DE2161344A1 (de) 1973-06-20
SU439956A3 (ru) 1974-08-15
AU473209B2 (en) 1976-06-17
CS189587B2 (en) 1979-04-30
FR2162637A1 (OSRAM) 1973-07-20
ATA1041972A (de) 1975-03-15
SE8400283L (sv) 1984-01-20
HU167086B (OSRAM) 1975-08-28
DE2161344C3 (de) 1986-10-02
GB1356076A (en) 1974-06-12
ES409464A1 (es) 1976-03-16

Similar Documents

Publication Publication Date Title
SE388542B (sv) Forfarande for framstellning av ett vaccin mot virushepatit
AR192775A1 (es) Un inoculador para administrar dosis medidas de preparaciones inyectables
DK114289B (da) Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera.
BE787901A (fr) Vaccin antivariolique
BR7200663D0 (pt) Ampolas hipodermicas descartaveis apos o uso
DK132243C (da) Natriumopvarmet dampgenerator
IT968560B (it) Dispositivo di avvolgimento e di variazione della corsa per la preparazione di avvolgimenti di filati e simili
AR204075A1 (es) Procedimiento para la produccion de una vacuna de virus atenuados que estimula los mecanismos naturales de defensa de un organismo hospedador sin ejercer simultaneamente una accion de antigeno
DK131439B (da) Natriumopvarmet dampgenerator.
DK132568C (da) Natriumopvarmet dampgenerator
AR200155A1 (es) Procedimiento para atenuar un coronavirus de la diarrera del ternero y procedimiento para producir una vacuna contra dicha diarrea
BR6574761D0 (pt) Processo para a preparacao de novas vacinas
CA962593A (en) Highly attenuated newcastle disease virus vaccine and production thereof
BR7205276D0 (pt) Unidade tubular geradora de vapor
BE821175A (fr) Preparation de vaccins a fragments de virus apyretogenes
AT315876B (de) Dampfkessel
CH541107A (de) Dampferzeuger
NO141565C (no) Fremgangsmaate for fremstilling av en vaksine mot klovsyke
DE2128626B2 (de) Oral verabreichbarer lebend-impfstoff gegen typhus
SU64573A1 (ru) Способ удалени горьких веществ из корней цикори
DK132470C (da) Natriumopvarmet dampgenerator
AU4984672A (en) Vaccine adjuvants
CH541957A (de) Impfgerät
AT318658B (de) Dampferzeuger
BR6912716D0 (pt) Processo para a preparacao de uma vacina